Summary. Thirty human insulinomas have been investigated histologically and their immunoreaetive insulin (IRI) content estimated. In most eases immunohistological and ultrastruetural studies were also performed and the percentage of proinsulin-like components (PLC) in the tumour determined. Except for 1 ease the II~I concentration in the tumours was lower (0.01--89.0 U/g) than in the islet tissue. Histologically, immunohistologically and ultrastrueturally a variable number of tumour cells contained few and often no beta-granules, indicating a decreased storage capacity for insulin. This defective storage capacity seems to be the major functional abnormality of insulinoma cells. Ultrastrueturally four types of insulinoma can be distinguished. The ultrastructural diagnosis of an insulinoma can only be made in t?~e I (typicai beta-granules, 13 cases) and type II (typieM and at~2pical granules, 7 eases) but, not in type III (atypical granules only, 4 eases) and type IV (virtually agranular, 4 eases). The type IV tumours had the lowest IRI concentration and did not respond to diazoxide treatmerit. The IRI concentration of the uninvolved pancreas of 19 patients was 2.0~0.2 U/g and in the range of nondiabetic adults. --The percentage PLC in 19 insulinomas was higher (5.3--22%) than in the pancreas of human adults with and without insulinoma (1.7--4.8%). The percentage of PLC in the serum of patients with insulinoma was always higher than in their tumours (33-61% ) . It is suggested that the higher PLC levels found in the tumour and serum of insulinoma patients are the consequence of the reduced storage capacity of the tumour cells resulting in a rapid passage through the granular route or even a non-granular release of newly synthesized insulin.
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The clinical syndrome hypoglyeaemia due to insulin-producing tumours of the pancreas is fairly uniform and the criteria for diagnosis are weli established. Insulin has been extracted in several series of hmctioning pancreatic adenomas and carcinomas [t2, 40, 52] . These reports have demonstrated that generally the cells of insulinomas ~ contain less insulin than normal B-cells. Therefore, it has been concluded that hyperinsnlinism in patients with an insulinoma is not due to an excessive production of insulin but to an inability to control its storage and release [12, 34] . Reports about ultrastruetural investigations of insulinomas are usually confined to single or few cases [3, 14, 20, 21, 25, 26, 28, 41] and, therefore, do not give sufficient information about the broad scale from nearly normal B-cells [3, 21, 25, 26, 28 ] to atypical cells [3, 14, 20] and the frequency in which they occur in different insulinomas. Of special interest is the correlation of the histology and ultrastrnctm'e of insulinomas with the insulin content of the tissue; this i The expression "insulinoma" is used throughout this article instead of "insulin-producing islet tumour" or "insulin-producing insulinoma" or "insulin-producing pancreatic tumour". The terminology stresses the fact that the main characteristic of these turnouts is their ability to produce and secrete insulin while their morphological appearance may vary and their origin is not yet defined.
information may be relevant for the suggested defect in insuiin storage and release and may explain the different response of patients with insulinomas to agents which block insulin release, like diazoxide. It has been claimed that this drug is effective only in patients with insulinomas which store insulin in granular form, while virtually agranular turnouts do not respond to diazoxide treatment [8, 9, 10] .
Since the discovery of proinsulin by incubating slices of insulinoma tissue in vitro [5t] and that this material could be detected in the circulation [43, 44] , different studies have demonstrated that patients with insulinomas have a higher percentage of proinsnlin or proinsulin-like components in their serum than normal persons [16, 17, 18, 22, 36, 49] . Again, it has been suggested that this phenomenon may be due to a defective storage mechanism of insulin [19, 36, 45] . However, from only 3 single cases has the proinsulin content of insutinomas been reported; in 2 it was elevated [18, 36] and in i within the normal range [29] . These data were not correlated with the ultrastructureal appearance of the tumours.
This study presents data collected from a series of 30 human insulinomas and correlates their insulin and proinsulin content with their histological and ultrastructural appearance. By comparing these data with the findings in the unaffected pancreas of the same Diabetologia cases a better understanding was sought of the mechanism of storage and release of insulin and its precursors in man under normal and pathological conditions.
Material and Methods
Thirty insulinomas (28 adenomas and 2 carcinomas) were collected during the last 7 years. All tumours have been obtained in the operation theatre immediately after extirpation. The tumour was measured (for evaluation of the weight) and divided with razor blades for histological and biochemical investigations. To avoid tissue damage during the extirpation a small piece of the tumour was excised before clamping off the vessels and fixed immediately for ultrastructural studies. In most cases normal pancreatic tissue was attached to the extirpated tumour or partial pancreatectomy was necessary. Thus biochemical and morphological investigations could be performed in the pancreas of 21 cases. For control pancreatic tissue of non-diabetic patients (suspected or proven Zollingcr-Ellison syndrome) was obtained during surgery. Pancreatic tissue of 3 patients was studied biochemically and morphologically and of 5 patients only morphologically.
Determination and fractionation of I RI in serum and tissue
Ii%I in serum was determined by a slightly modified standard procedure [35] using anti-porcine guinea pig serum, 12SI-porcine insulin (Hoechst), and crystalline human insulin (Novo Research Institute) as reference standard.
Tissue from pancreas and tumours (300 to 800 rag) was extracted twice with 5 ml of acid-ethanol (375:105:7.5; ethanol: H20:HC1 ). The serum (50 to 75 ml) was extracted once with 10 vol. of acid-ethanol (375:7.5; ethanol:HC1). Aliquots of the tissue extract were neutralized and assayed for IRI by a back titration procedure [33] using anti-porcine guinea pig serum and 12SI-porcine insulin. The acid-ethanol extracts of the tumour and pancreas tissue and of serum were chromategraphed on Sephadex LH-20 (tissue extracts: 2.5x20 cm; serum extracts: 8• 30 cm) with 1 N acetic acid. In both cases the void volume was pooled, lyophilized and rechromatographed on Sephadex G-50 fine (2.0 • 95 cm) in 1 N acetic acid/0.15 M NaC1. Successive 1 ml fractions were assayed for Ii~I [35] ; when samples had to be assayed at low dilutions, 0.5 M phosphate-buffer (pH 7.4) was used instead of 0.1 M borate-buffer.
Histology
Tissue samples of the tumours and the adjacent panereas were fixed in Bouin's fluid and embedded in paraffin. Thin sections were stained with hematoxylin eosin and aldehyde-thionin [38] . Immunohistology was performed as described previously [1] . The amount of connective tissue in the tumour was roughly estimated and the aldehyde-thionin stained sections were evaluated for the percentage of stained and unstained endocrine cells and the intensity of the staining reactions in the stained B-cells. The antiserum has about a 50% lower affinity for bovine proinsulin than human insulin on a molar basis
Calculation of percentage of proinsulin-lilce component (PLC)
By chromatography of the extracts on Sephadex G-50, two major peaks of IRI were detected. The first peak of several tumour extracts was exposed to limited tryptic hydrolysis yielding IRI-material eluting in the position of the second peak, insulin. Thus, the first peak contained 1)CL and the second insulin. The IRI in the PLC (peak I) was expressed as a percentage of the total IRI (peak I plus peak II). Crystalline human insulin 2 served as the reference standard in these assays. Bovine proinsulin s was tested in the assay system to determine its affinity to the antibody (the same lot of guinea pig antiinsulin serum being used throughout all of these experiments). Compared with equimolar quantities of human insulin, the bovine proinsulin was about 50% less active in displacing 125I-insulin (Fig. 1) . No correction for this underestimation of PLC was made. 
Electron microscopy
For electron microscopy the tissue was immediately fixed by immersion in Karnovsky's fixative buffered with 0.1M sodium cacodylate with 0.03% calcium chloride. After 3 h the tissues were washed overnight in the same buffer and transferred to 2% osmium tetroxide in sodiumcacodylate buffer. After rinsing, the tissue was dehydrated in a graded series of acetone and embedded in vcstopal. Ultra-thin sections were cut on an LKB ultramicrotome, picked up on formvar-coated copper grids and stained with uranyl acetate and lead citrate [6] . The sections were viewed in the Zeiss electron microscope EM 9 S with a built-in condenser.
In the electron micrographs (frequently using photomontage for reconstruction of larger areas) the following findings were evaluated: The frequency and the type of secretory granules in comparison with normal B-cells of human islets of Langerhans and the development of the rough endoplasmic retieulum and number of small cytoplasmic vesicles depicting the degree of functional activity.
Results
All individual data of the investigated cases relevant to this study are given ha Table 1 . Here, the cases are listed according to the date of operation. The case numbers of T~ble 1 are nseA throughout the text, and the figures.
Clinical findings
The clinical findings in these 30 patients may be briefly summarized as follows. 800/showed, after an overnight, fast blood glucose levels below 50 mg/i00 ml were treated with diazoxide preoperatively. Twenty responded well, while 4 did not respond (2 patients with B-cell adenoma and 2 patients with B-cell carcinoma). The observations dm'ing treatment with diazoxide in some of the cases have been described and discussed previously [8, 13] . Table t ) are written at the top of each column and 90% serum insulin (IRI) levels above 50 ~U/ml (if investigated frequently). Excessive serum insulin concentrations were found in 80% of the patients after challenge with glucose, tolbutamide or glucagon. There were no correlations between the insulin concentration or content of the tumours and the IRI release after glucose, tolbutamide or glucagon stimulation [d. 12, 40] . The best test for establishing the diagnosis wgs prolonged fasting (up to 36 h) : All patients showed, after prolonged fasting, hypog]ycaemie symptoms accompanied by low glucose levels and responded promptly to glucose injection. Twenty four patients the lowest insulin concentration (0.0t and 0.2 U/g). These 2 cases and 2 further patients with the next lowest insulin concentration in their turnouts (0.75 and 1.1 U/g) did not respond to diazoxide. The IRI concentration in the pancreas has been estimated in 21 cases (Fig. 2) . It ranged from 0.49 to 4.85 U/g wet weight (mean-= 2.0J=0.2). The insulin concentrations in the pancreas of 3 non-diabetic patients without an hasulinoma were in the same range (0.77, 1.2 and 1.9 U/g). Assuming an islet volume of i per cent of the pancreas, only in 1 out of 30 insutinomas (case INTo. 2) did the turnout cells contain as much insulin as the normal B-cells; the majority of the tumours contained much less insulin per cell. Fig. 3 gives the total insulin content, (mean 82 12 U) of the tnmours and the pancreatic glands, assuming the average weight of the pancreas to be 100 g. 0nly 2 eases contained more insulin in the tumour than the mean value of all pancreatic glands (mean 200_% 20 U); none more than the pancreas with the highest insulin content,. Even by adding the insulin content of the turnout and the pancreas for each ease total IgI concentration are listed in Fig. 4 . The PLC ranged in the pancreas of patients with insulinomas from 1.7 to 4.8% (mean 2.5d=0,2), The values in the pancreas from non-diabetic patients without insulinoma were in the same range (2.0, 2.0 and 3.0%). The PLC values in the insulinomas ranged from 5.3 to 22.0% (mean 13.8 • 0.8). Thus, they were significantly higher (p < 0.0t) than in the pancreas. A nearly normaI value was found in case No. 24. This case had the highest IgI concentration (89.0 U/g) of nil turnouts in this sum surpasses only in four cases the highest insulin content of the pancreas. Only in 11 cases did the total insulin amount stored in the tumour and the pancreas exceed the mean insulin content of the normal pancreas. Generally, the highest percentage of PLC was found in the tumom's with the lowest IRI concentration. However, this correlation was not significant (r = 0.579) even if the IgI concentration was corrected according to the different content of connective tissue in the turnouts.
Insulin concentration in turnouts and pancreas

Proinsulin-like components ( PLC) in turnouts, panere, as and serum
The PLC content of the serum was estimated in 6 cases during glucose load. The levels were much higher than in the tumour extracts (33--61%). Fig. 5 gives an example of the concentration pattern of PLC in the tumour and the serum of case No. 17.
Histological findings
All 28 insulinomas were investigated histologically. The 26 adenomas consisted of islet-like cells which formed either solid, ribbon-like or acinar arrangements. 3iitoses were observed extremely rarely.
In some tucords and nests of endocrine cells varied considerably between the tumours, Since this is of relevance for the interpretation of the insulin concentration in the turecurs, the percentage of connective tissue was roughly estimated in each case. The results are listed in Table 1 . Some tumours contained amyloid. However, this finding will be discussed in a separate publication.
In the aldehyde-thionin stained sections only few tumours showed a very strong staining reaction similar to normM human islets of Langerhans. More frequently, Table 1 . From these data it can be tentatively concluded that the aldehyde-thionin stain is most intensive in the tumours with the highest IRI concentration, especially Diabetologia considering the amount of connective tissue present in the tumour. The same general conclusion can be reached regarding the percentage of PLC. This is highest in the aldehyde-thionin negative tumours and only slightly elevated in those insulinomas in which the majority of the cells react strongly (Table 1) . Thus, the less unstained cells are present in an insulinoma, the lower the percentage of PLC seems to be in the tumour extract. Some exceptions to this general pattern have been observed in tumours with insulin concentrations from 5--10 U/g and, despite, this showing virtually no cases the cells sometimes differed considerably in different areas of the tumour. The mai ority of the tumours contained cells with secretory granules as seen in normal B-cells of human islets of Langerhans. These were of two types: 1. electron-dense (multishaped or round) and surrounded by a membranous sac encompassing an electron lucent space; 2. pale and round with only a small or no space between the granule and the limiting membrane (Fig. 6 ). The frequency of these different granule types varied as it does in the norreal B-cells and showed no correlation with either the in- For details see Fig. 2 aldehyde-thionin positive cells. At the same time the imm~mohistological reaction for insulin was strongly positive in many cells. However, this reaction is, according to published findings [1] , mainly a qualitative one, indicating the presence but not the amount of insulin in the cells as the aldehyde-thionin stain does. Only in turnouts with insulin concentrations below 1,0 U/g was the immunohistological reaction negative.
Ultrastructural findings
Twenty eight of the 30 insulinomas were investigated ultrastructurally. The ultrastructural appearance of the tumours was not uniform. Even in individual suli~ content or PLC content of the tumours. In addition to these typical beta -granules, atypical granules occurred either in the same cells or in different cells of the same tumour (Fig. 7) . Few tumours revealed only cells containing such atypical secretory granules. These atypical secretory granules were electron-dense and round, usually smaller than normal beta-granules and had only tightly fitting or no discernible membranes (Fig. 8) . Such granules can be seen also in other endocrine tumours and do not allow the diagnosis of an insulinoma. Since turnouts with only atypical secretory granules often showed a strongly positive immunohistological reaction and contained appreciable amounts of Itl,I, it is concluded that insulin can be stored in this abnormal form in some tumours. The aldehyde-thionin stain was mostly negative in tusecretory granules some cells in each tumour were only poorly granulated or ~drtually agranular (Fig. 9 ). These cells often showed signs of high functional (Fig. 10) . Their insulin content was extremely low (0.0i to i.1 U/g) and the patients did not respond clinically to diazoxide treatment. They also contained high levels of PLC.
Other islet cells (A-cells and ])-cells)
were not found with certainty in the tumours. However, in many tumours single cells were observed which resembled the enteroehromaffin cells (EC-eells) found in the gastrointestinal mueosa and in eareinoid turnouts. These EC-eells were most frequent in the two carcinomas (Fig. 11 ). According to their nltrastrueture, the 28 insulinomas can be categorized into the follo~dng four types :
I. Turnouts with cells containing secretory granules typical for human islet B-cells (Fig. 6) .
II. Turnouts with cells containing typical and atypical secretory granules (Fig. 7) . Diabetologia I I I . Tumours with cells containing only atypical secretory granules (Fig 8) .
IV. Tumours which only contain virtually agranular cells (Fig. 10) . addition, the I R I concentration and the percentage of PLC is listed. From this it can be eo~eluded that in the type I tumours, which are most frequent, the II~I concentration is highest and PLC content least ele- []a Number of cases investigated for PLC.
I n type I I I and I V the diagnosis of an insulinoma is not possible on ultrastruetural grounds and with granule stains. Table 2 gives the frequency with which the different ultrastruetural types were found. I n vated. The type I V tumours have the lowest insulin concentration and highly elevated PLC levels. Type I I and I I I are in between both these extremes. A correlation between ultrastructural findings and I R I and PLC concentration is more evident ff the number of agranular cells is also accounted for: the more virtually agranular ceils in a tumour, the lower the It~I concentration and the higher the percentage of PLC.
insulinomas responsible for the clinical picture of pernicious hyperinsulinism.
The present biochemieal results confirm the observation [12, 15, 40, 52 ] that insulinoma cells con- The ultrastructure of the islets of Langerhans of the normal pancreatic tissue revealed no abnormalities compared to the islets of non-diabetic persons without insulinoma. The frequency and type of beta-granules (multishaped or round dense granules and pale granules) varied from case to case. A-and D-cells showed their characteristic type of granules.
Discussion
The purpose of this study was to collect data from a large series of insulinomas regarding insulin content, PLC content, histology and nltrastructure. Previous studies reported upon only one or two of these parameters from a limited number of tumours. The results did not allow any conclusions regarding the frequency of abnormalities and the general functional defect of tain less insulin than normal human B-cells. Great differences between single tumours were found (Fig. 2) . The lowest values were found in the 2 carcinomas. Only one out of 30 insulinomas had an I g I concentration in the range of normal B-cells. Only 2 other cases have been reported with comparable high insulin levels [23, 29] . The decreased insulin contents cannot be attributed to the content of connective tissue or amyloid in most cases (Table 1) . A low insulin content has also been found in mierodisseeted cells of insulinoma tissue [15] .
The biochemical result can be correlated with histological, immunohistological and ul~rastructural findings. Only in the turnout with an insulin concentration comparable to islet B-cells (case No. 2) did practically all insulinoma ceils react strongly with aldehyde-thionin, a specific stain for beta-granules. In the other tumours a variable number of eells were less intensively Diabetologia stained or gave no reaction. The semi-quantitative evaluation of the histological findings correlated relatively well with the I R I concentration of the tumours (Table 1) with the exception of those tumours which contained, ultrastructurally, only atypical granules and were aldchyde-thionin negative (ultrastruetural type III). However, in these cases the immunohistologieal reaction was positive and its intensity and distribution correlated well with the I R I concentration of the tumours. These findings indicate that nearly all insulinstored in the tumour and in the pancreas exceed the mean insulin content of the normal pancreas.
The ultrastructural analysis of the insulinomas did not reveal any general abnormality which could explain this decreased storage capacity. Thirteen of 28 turnouts had cells indistinguishable from normal islet B-cells, with the exception that a variable number of cells contained only few or no beta-granules, again consistent with the II~I concentration. This finding does not support the suggestion that the inability to omas contain cells which do not store insulin as competently as normal B-cells; this suggests a decreased storage capacity as a major characteristic of the turecur cell [12, 34] . The resulting uncontrolled release of insulin in the fasting state, i.e. in the presence of normal or even low blood glucose concentration and without additional physiological stimulation, could adequately explain the hypoglycaemic reactions of insulinoma patients. The total amount o2 extractable I R I from tumours rarely surpassed that found in the pancreas. Only in 11 cases did the sum of the insulin store insulin is reflected ultrastructurally by irregular and pleomorphic beta-granules [34] . Atypical betagranules, in addition to normal beta-granules, were found in 7 cases (ultrastructural type II) and only atypical granules in 4 cases (ultrastruetural type III). However, the mean tumour insulin concentration in these cases was only slightly lower, with considerable overlap, than the other groups ( solely by tfltrastruetnral findings. The same experience has been made with proven pancreatic gastrinomas, which frequently" reveal secretory granules dissimilar to antral G-eells or islet D-cells [20, 53a , own unpublished observations]. In the present series, the diagnosis of an insulinoma was based upon biochemieal analysis of the tumour extract (IRI concentration) in all eases and immunohistologieal investigation (1) in most eases (especially in those which were aldehydethionin negative). The frequent finding o f atypical granules in insulinoma cells and the occurrence of virtually agranular tumours shows that nttrastruetural analysis of a panereatie endocrine turnout alone is insufficient for definite identification. Eight of the 28 tumours studied ultrastructurally could not be identified as insulinomas by their ultrastruetural appearance alone. Considering the occurrence of other hormone-producing turnouts of the panereas (gastrinoma, glucagonoma and diarrheogenic tumours) and of non-functioning endocrine tumours, caution is necessary in the identifieation of insulinomas lgegarding the genesis of the insulinomas, the present observations support the view that they originate from duetular elements [3, 28] . In practically all eases dose eormcctions of the turnouts to ductnlar structures were found. It cannot be decided, however, from these observations if the duetnlar structures consist of non-endocrine duetules or of immature endoerine ceils, sinee regenerating and phylogenetitally primitive and ontogenetieally immature islet tissue has the tendency to form tubular struetures [28b] .
Diabetologia
Extremely low insulin concentrations have been reported in the pancreas uninvolved by tumour in 2 of 3 [52] and 2 of 4 [12] cases. This has been explained by suppression of the normal islet tissue by the tnmour induced hyperinsulinaemia, comparable to the effect of prolonged insulin injection in animals [4, 23, 27, 31, 32] . In the present series, the mean insulin concentration of the uninvolved pancreas of 21 patients was 2.0 ~ 0.2 (range 0 . 4 9 -4.85) U/g. These values did not differ from the insulin concentration in the pancreas of This fact is relevant to the evaluation of the percentage of proinsulin-like components (PLC) found in the pancreas and in the tumour since nothing yet is known about PLC percentages in the adult human pancreas. Considering the finding of normal insulin concentration in the pancreas of patients with insulinoma and the fact that the PLC pereenta,ge of 3 non-diabetics without insulinoma was in the range of the pancreatic glands of 9 patients with insulinoma suggests that M1 these PLC values are normal. Table 1) • 24000 3 non-diabetic subjects and are comparable with published data. The insulin concentration of the pancreas of non-diabetics has been reported being 1.7 (range 0.6 --3.8) [48] , 2.37 ~ 0.i4 (range 0.5 --4.5) [54] , and 2.15~0.33 (range 1.0--3.9) [52] U/g pancreas. Thus, it can be concluded that the presence of an insulinoma usually does not affect the insulin concentration i.e. the storage of insulin in the normal islets. The biochemical data are supported by the histological, immunohistological and ultrastructural investigations of the islets of Langerhans, which revealed completely normal B-cells.
Very close to the findings in pancreas of rat and beef [50] , pig and rabbit [30] and human fetuses [42] , which contained tess than 5% of the total extractable II~I as proinsulin, is the percentage of PLC in the adult human pancreas (mean 2.5 ~= 0.2; range 1.7 --4.8). The P L C percentage of tile 19 investigated tumours were above these values (m = 13.8 :L 0.8; range 5 . 3 -22%). So far only 3 single cases of insulinoma have been analyzed for the PLC content of the tumour; the following values were found: 27% [36] , 16% [18] and 5% [29] . In contrast, many studies have uniformly demonstrated that the percentage of PLC in the serum is markedly elevated in cases of insulinoma [16, 17, 18, 22, 36, 49] . Twice, as exceptions, normal serum values have been reported [29, 46] . In the present study, the serum PLC were estimated in 6 eases and found to be markedly elevated (33 --61~o). I t was much higher than in the turnout of the same eases (Table 1) . This difference could be explained by the reported longer half-life of proinsulin than insulin in the plasma [45] .
To explain the elevated serum PLC levels in ingranule formation) should lead to increased proinsulin levels. The finding of an increased percentage of PLC in all 19 investigated insulinomas and decreased storage of insulin in virtually all tumours strongly supports this hypothesis. By correlating the percentage of PLC in the tumours with the histological and ultrastructural findings, it is evident that the percentage of PLC is correlated to the number of poorly granulated or agranular tumonr cells. The differences between the ultrastructural types I --I V are not significant (Ta-; Fig. 11 . EC-cell in an insulin-producing carcinoma of the pancreas. Comma-shaped granules of high electrondensity. (Case No. 23, Table 1) • 24000 sulinoma cases a relative or absolute deficiency of the converting enzymes [45] or a defective storage mechanism [19, 45] in the tumours have been suggested. No data have been presented to substantiate the first suggestion. The second explanation is supported by the fact that the percentage of serum PLC is higher in the fasting state than after stimulation (i.e. after release of stored insulin) and most markedly elevated in cases having poorly granulated tumour cells [19] . Since evidence is accumulating that the conversion of proinsulin to insulin takes place only in the Golgi apparatus and granules [24] a defect in storage capacity (i.e. ble 2). Recent observations are in agreement with this concept. In contrast to an earlier report [47] , it was shown that under stimulated conditions a preferential (non-granular) release of newly synthesized proinsulin/insulin occurs from isolated rat islets [53] and that incubated human insulinoma tissue has the capacity for a higher rate of proinsulin and insulin turnover than normal islet tissue [7] . Thus the increased PLC in the tumour and serum of patients with insulinoma seems to be the consequence of the decreased storage capacity of the tumour cells resulting in a shortened passage through the granular route or even a non-granular release of newly synthesized proinsulin and insulin. The response to diazoxide was not directly correlated to the percentage of PLC. However, the 4 of the 24 tested patients who did not respond to this drug had the lowest insulin concentration in the tumour and revealed nltrastructurally only virtually agranular cells. Two were the carcinoma patients. Unresponsiveness to diazoxide has been described in patients with islet cell carcinoma [5, 18, 39] . Also a transplantable islet cell carcinoma of the golden hamster did not respond to diazoxide with a decrease of the plasma insulin levels [28a] . This tumour consisted primarily of agranular or sparsely granulated cells occasionally containing round granules of the g-type [10a] . After incubation of human islet carcinoma tissue with diazoxide in vitro only proinsulin could be detected in the medium, suggesting insulin, but not proinsulin, release was inhibited by the drug [22@ These findings support the hypothesis that diazoxide mainly blocks granular release from the B-cells [9, 10] .
